[HTML][HTML] Metformin and insulin resistance: a review of the underlying mechanisms behind changes in GLUT4-mediated glucose transport

…, NA Kravos, M Jensterle, A Janež, V Dolžan - International journal of …, 2022 - mdpi.com
Metformin is the most commonly used treatment to increase insulin sensitivity in insulin-resistant
(IR) conditions such as diabetes, prediabetes, polycystic ovary syndrome, and obesity. …

[HTML][HTML] Alcohol-induced oxidative stress and the role of antioxidants in alcohol use disorder: a systematic review

EE Tsermpini, A Plemenitaš Ilješ, V Dolžan - Antioxidants, 2022 - mdpi.com
Alcohol use disorder (AUD) is a highly prevalent, comorbid, and disabling disorder. The
underlying mechanism of ethanol neurotoxicity and the involvement of oxidative stress is still not …

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

…, RM Turner, MH van Rhenen, CLD Fajardo, V Dolžan… - The Lancet, 2023 - thelancet.com
Background The benefit of pharmacogenetic testing before starting drug therapy has been
well documented for several single gene–drug combinations. However, the clinical utility of a …

[HTML][HTML] SGLT2 inhibitors in the treatment of diabetic kidney disease: more than just glucose regulation

J Klen, V Dolžan - Pharmaceutics, 2023 - mdpi.com
Diabetic kidney disease (DKD) is a severe and common complication and affects a quarter
of patients with type 2 diabetes mellitus (T2DM). Oxidative stress and inflammation related to …

Implementing pharmacogenomics in Europe: design and implementation strategy of the ubiquitous pharmacogenomics consortium

…, VH Deneer, V Dolžan… - Clinical …, 2017 - Wiley Online Library
Despite scientific and clinical advances in the field of pharmacogenomics (PGx), application
into routine care remains limited. Opportunely, several implementation studies and …

Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism

…, D Logar, B Lestan, V Dolžan - European journal of …, 2008 - Springer
Objective Methotrexate (MTX) is a disease-modifying antirheumatic drug used in the treatment
of rheumatoid arthritis (RA). Genetic polymorphisms of reduced folate carrier (RFC1 A80G)…

Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and …

…, I Grabnar, P Bohanec Grabar, V Dolžan… - European journal of …, 2011 - Springer
Purpose The objectives of this study were (1) to develop a population pharmacokinetic
model of high-dose methotrexate (HD-MTX) in children with acute lymphoblastic leukaemia (ALL) …

Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia

V Dolžan, J Sólyom, G Fekete, J Kovács… - European Journal of …, 2005 - academic.oup.com
Objective To analyze the mutational spectrum of steroid 21-hydroxylase (CYP21) and the
genotype– phenotype correlation in patients with congenital adrenal hyperplasia (CAH) …

Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients

…, M Tomšič, D Šuput, D Logar, V Dolžan - European journal of …, 2008 - Springer
Objective Leflunomide is a disease-modifying antirheumatic drug used for treating
rheumatoid arthritis (RA). In vitro studies demonstrated that cytochromes P450 (CYPs), mainly …

[HTML][HTML] Viral protein Nef is detected in plasma of half of HIV-infected adults with undetectable plasma HIV RNA

J Ferdin, K Goričar, V Dolžan, A Plemenitaš, JN Martin… - PloS one, 2018 - journals.plos.org
Objective To address the role of translationally active HIV reservoir in chronic inflammation
and non-AIDS related disorders, we first need a simple and accurate assay to evaluate viral …